Aging
Navigate
Research Paper|Volume 2, Issue 8|pp 487—503

Nutrient withdrawal rescues growth factor-deprived cells from mTOR-dependent damage

Emiliano Panieri1, Gabriele Toietta3, Marina Mele1, Valentina Labate1, Sofia Chiatamone Ranieri1, Salvatore Fusco1, Valentina Tesori1, Annalisa Antonini3, Giuseppe Maulucci2, Marco De Spirito2, Tommaso Galeotti1, Giovambattista Pani1
  • 1Institute of General Pathology, Laboratory of Cell Signaling, Catholic University Medical School, Rome Italy
  • 2Institute of Physics and Microscopy Core Facility, Catholic University Medical School, Rome Italy
  • 3Vascular Pathology Laboratory, Istituto Dermopatico dell'Immacolata - IDI- IRCCS, Rome, Italy

* * Equal contribution

Received: August 1, 2010Accepted: August 22, 2010Published: August 24, 2010

Copyright: © 2010 Panieri et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Abstract

Deregulated nutrient signaling plays pivotal roles in body ageing and in diabetic complications; biochemical cascades linking energy dysmetabolism to cell damage and loss are still incompletely clarified, and novel molecular paradigms and pharmacological targets critically needed. We provide evidence that in the retrovirus-packaging cell line HEK293-T Phoenix, massive cell death in serum-free medium is remarkably prevented or attenuated by either glucose or aminoacid withdrawal, and by the glycolysis inhibitor 2-deoxy-glucose. A similar protection was also elicited by interference with mitochondrial function, clearly suggesting involvement of energy metabolism in increased cell survival. Oxidative stress did not account for nutrient toxicity on serum-starved cells. Instead, nutrient restriction was associated with reduced activity of the mTOR/S6 Kinase cascade. Moreover, pharmacological and genetic manipulation of the mTOR pathway modulated in an opposite fashion signaling to S6K/S6 and cell viability in nutrient-repleted medium. Additionally, stimulation of the AMP-activated Protein Kinase concomitantly inhibited mTOR signaling and cell death, while neither event was affected by overexpression of the NAD+ dependent deacetylase Sirt-1, another cellular sensor of nutrient scarcity. Finally, blockade of the mTOR cascade reduced hyperglycemic damage also in a more pathophysiologically relevant model, i.e. in human umbilical vein endothelial cells (HUVEC) exposed to hyperglycemia. Taken together these findings point to a key role of the mTOR/S6K cascade in cell damage by excess nutrients and scarcity of growth-factors, a condition shared by diabetes and other ageing-related pathologies.